Data as of Mar 12
| +0.26 / +0.80%|
The 8 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 38.50, with a high estimate of 50.00 and a low estimate of 27.00. The median estimate represents a +17.34% increase from the last price of 32.81.
The current consensus among 8 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.